FDA panel endorses Johnson & Johnson ketamine nasal spray for treatment-resistant depression.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA discourages people against 'young blood' infusions, which make unproven claims to reverse agingThe FDA is advising against 'young blood' infusions, in which people are infused with plasma from young donors. It warns consumers that clinics are making unproven claims that the treatment can reverse aging.
Baca lebih lajut »
FDA warns against using young blood as medical treatmentThe US Food and Drug Administration warned against using plasma infusions from young blood donors to ward off the effects of normal aging as well as other more serious conditions.
Baca lebih lajut »
'Young blood' treatments to stop aging, disease are a 'significant public health concern': FDA
Baca lebih lajut »
'Young blood' company Ambrosia halts patient treatments after FDA warningThe FDA warned consumers against infusions of plasma from young donors, saying there is no evidence that they slow aging or memory loss, and can be dangerous.
Baca lebih lajut »